Navigation Links
CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
Date:3/5/2008

s. Severe cutaneous and mucocutaneous reactions have been reported. The most serious adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health care professionals qualified by training and experience in the safe use of radionuclides.

Patients and healthcare professionals can visit http://www.zevalin.com for more information.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the development of Zevalin include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with Zevalin in particular including, without limitation, the potential failure of Zevalin to prove safe and effective in further studies in combination with CHOP for first-line treatment of elderly patients with diffuse large B-cell lymphoma or to be developed further in this combination for this indication, determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of d
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
2. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
3. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
4. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
5. UCB Announces New Data Showing Investigational Drug Lacosamide Significantly Reduced Seizures in Refractory Epilepsy Patients
6. Survival Data Presented From Phase II Study of Investigational Drug ZD4054 in Hormone-Resistant Prostate Cancer Patients
7. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
8. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. Tom Shaws NFL Training Center Chooses SURGEX(TM) as Their Exclusive Post Training Nutritional Regimen
11. Anthrax vaccine produces immunity with nanoparticles, not needles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Flagship Biosciences LLC, a leading provider of ... and medical device industries, has announced a laboratory and ... has consolidated its histology and tissue analysis operations from ... just north of Denver. The new addresses are: ... Suite 100, Westminster, CO 80021 , Tissue Image Analysis ...
(Date:8/27/2014)... 2014  ARCH Venture Partners, one of the ... development of seed and early-stage advanced technology companies, ... with more than $400 million in subscriptions. ARCH ... target by more than $150 million. ... and potential of our approach to finding and ...
(Date:8/27/2014)... BIOEQUA, an innovative line of skin care ... handheld spray, has made its EQUA ESSENTIAL line available ... brand began with an unexpected discovery in an emergency ... that the application of nanospray technology allowed for liquid ... to skin's basal layer. This resulted in immediate absorption ...
(Date:8/27/2014)... 2014 Remcom announces an update to ... features for the biomedical industry. The central biomedical ... Sensor, exclusive to the Bio-Pro version of the software. ... developed to calculate the biological effects of electromagnetic fields. ... to all versions to expand engineers’ post-processing options. , ...
Breaking Biology Technology:Flagship Biosciences Announces Relocation and Expansion 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... has implemented IBM s eServer BladeCenter JS20 as ... proteomics research. IBM announced last month the BladeCenter JS20 ... will begin shipping in volume globally in April 2004. ... Sequest application on the JS20 running SUSE LINUX. Sequest is ...
... the future workforce have recently been issued by the ... think tanks on economic, political and social issues. Both ... are about to change dramatically as a result of ... gain momentum. The result will be a vastly different ...
... Lithuania or Hong Kong what they know about Wisconsin, chances ... beer, brats, cheese or the Green Bay Packers. But how ... if anything. However, its vital to Wisconsins economic future that ... technology assets from its great research institutions to its ...
Cached Biology Technology:Medical College of Wisconsin enhances research with IBM Blade server 2Are you ready to play the new talent management game? 2Are you ready to play the new talent management game? 3When its parts pull together, Wisconsin can tell a compelling economic story 2
(Date:8/28/2014)... Dyslexia, the most commonly diagnosed learning disability ... disability that occurs when the regions of the ... , The use of non-invasive functional neuroimaging tools ... in dyslexia. However, most prior work has focused ... leaving a gap in our understanding of how ...
(Date:8/28/2014)... of new roads will be built worldwide by 2050. ... wildernesses, where they bring an influx of destructive loggers, ... study has created a ,global roadmap, for prioritising road ... competing demands of development and environmental protection. , The ... that natural importance of ecosystems and a ,road-benefits, layer ...
(Date:8/28/2014)... . Cars, planes ... of sophisticated assembly lines. Mobile assembly carriers, on to which ... assembly lines. In the case of a car body, the ... a precise spatial and chronological sequence, resulting in a complete ... of such an assembly line at molecular level has been ...
Breaking Biology News(10 mins):Dyslexic readers have disrupted network connections in the brain 2Study shows where on the planet new roads should and should not go 2Study shows where on the planet new roads should and should not go 3Nanoscale assembly line 2Nanoscale assembly line 3
... German . What happens if you cannot recall ... name and face of a person, yet you might be unable ... the recall of the information is temporarily impaired. How such associative ... great mysteries of modern neurobiology. Now, scientists from the Max Planck ...
... basis of the most pessimistic and severe scenarios for conditions ... 2080, the oak woods of the Basque Country ... habitat, given that, in our territory, wooded areas will not ... development. Neiker-Tecnalia experts consider that this study illustrates the tendency ...
... scombrids (tunas, bonitos, mackerels and Spanish mackerels) and billfishes ... Red List of Threatened SpeciesTM. Of the 61 known ... at serious risk of extinction. Four species are listed ... in the Least Concern category. The results show ...
Cached Biology News:How memory is read out in the fly brain 2How memory is read out in the fly brain 3Climate change may alter conditions for growth of oak trees in Euskadi 2Increased protection urgently needed for tunas 2Increased protection urgently needed for tunas 3
... be upgraded to the GenePix Autoloader 4200AL. ... and saves results for up to 36 ... the batch is complete. Line-by-line autofocus ensures ... GenePix Pro gives you complete flexibility to ...
... Maximize the value of your microarray data ... support you need from consultation to extensive ... date methods. Utilize our expertise in combination ... from your own microarray experiments., ,Normalization and ...
... the value of your microarray data ... the support you need from consultation ... most up to date methods. Utilize ... Gene Expression Profiling Service or from ...
... This CLS number is a ... easily match Cornings product number. ... please order under the old ... customer service for assistance. ...
Biology Products: